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Preface
Never before in human history has the gap between the scientific and economic
potential for better health for all and the reality of avoidable premature death
been greater. In the past, babies died in infancy, women in childbirth, workers
from injuries or occupational diseases, and people of all ages from epidemics
of infectious disease exacerbated by inadequate nutrition, contaminated water,
and poor sanitation. For the most part, the world lacked the resources and the
understanding to eliminate these problems. As societies developed; as science,
technology, and medicine advanced; and as people organized to improve their
standards of living, more and more of the world’s population attained the living
conditions that support better health and longer lives.
Today, the world still confronts the global health challenges of the last century.
Epidemics of malaria, HIV infection, tuberculosis, and other communicable
diseases still threaten well-being and economic development in many poor
countries. More than a billion people live in urban slums where the average lifespan
can be 35 years, half of that in better-off places where residents have certain
access to adequate nutrition, clean water, and sanitation.
Now new threats have emerged. Deaths from chronic conditions like heart
disease, cancer, diabetes, and stroke have surged, today accounting for more
than 60 percent of the world’s deaths. Injuries have become the leading cause
of death for young people around the world. Everywhere, from the wealthiest
nations like the United States to the poorest countries in Africa, Asia, and Latin
America, the proportion of deaths from these causes of death are growing. Th ese
premature deaths and preventable illnesses and injuries impose new suffering on
individuals, families, and communities. They burden economies and taxpayers
and jeopardize the improvements in health brought about by the public health
advances of the previous two centuries.
Alarmingly, these new epidemics are not the result of the poverty and squalid
living conditions that caused illness and death in the past, even though chronic
disease and injuries afflict the poor much more than the rich. Nor are they the
result of ignorance and inadequate science. For the most part, we understand the
causes of these illnesses and injuries enough to prevent them. What we lack is
the political will to implement the needed preventive measures. Even worse, in
some cases the growing health burden is the result of new science and technology,
which have been used to promote profit rather than prevent illness. These
new epidemics of chronic diseases and injuries are instead the consequence of
what most people thought were the remedies for poverty-related ill health: economic
growth, better standards of living, and more comfortable lifestyles.
While many factors contributed to this global health transformation, Lethal
but Legal focuses on what I consider to be most important and most easily
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modifiable cause: the triumph of a political and economic system that promotes
consumption at the expense of human health. In this book, I describe
how this system has enabled industries like alcohol, automobiles, fi rearms, food
and beverages, pharmaceuticals, and tobacco—pillars of the global consumer
economy—to develop products and practices that have become the dominant
cause of premature death and preventable illness and injuries. This system was
born in the United States and has now spread around the world.
In a global economy that focuses relentlessly on profit, enhancing the bottom
line of a few hundred corporations and the income of their investors has
become more important than realizing the potential for good health that the
world’s growing wealth and the advances in science, technology, and medicine
have enabled. This tension between private accumulation and public well-being
is not new. But in the twenty-first century, it has come to shape our economy and
politics in ways that profoundly threaten democracy, human well-being, and the
environment that supports life. Paradoxically, the increasing concentration of
power in the small number of the world’s multinational corporations also presents
new opportunities to create another healthier and more just future.
In Lethal but Legal , I argue that, for the United Sates and the world to achieve
their articulated goals of better health for all and a more equal distribution of
advances in health, we will need to redesign the system that has evolved to promote
consumption at the expense of well-being. Succeeding in this task will
require taking on the world’s most powerful corporations and their allies. Only
the naive or foolish would underestimate the enormity of this challenge. But
neither nature, human evolution, nor fate created the new burdens of chronic
diseases and injuries. Rather, it was human decisions, made in corporate boardrooms,
advertising and lobbying fi rms, and legislative and judicial chambers.
In the last few decades, the directors of a few hundred corporations have
changed the world to suit their needs, and as a result set the stage for the
twenty-first–century epidemics. Surely the world’s people, supported by social
movements, honest governments, health professionals, and scientists can take
back our health, as we have done so many times before when special interests
challenged human well-being.
Three paths led me to write this book. First, as a public health practitioner,
I have worked for three decades with community and advocacy organizations,
churches, government agencies, and other researchers to develop, implement,
and evaluate programs and policies to improve the health of low-income populations.
In these efforts, this work has frequently come into conflict with special
interests. Paint companies and landlords opposed efforts to eliminate childhood
lead poisoning because it jeopardized profits. Pharmaceutical companies
charged so much for the drugs that could have kept HIV infection or diabetes
under control that the people who needed these medicines could not afford
them. Fast food and soda companies promoted their high fat, sugar, and calorie
products to children who were becoming obese and overweight and therefore at
high risk of diabetes and other diet-related diseases. When the groups I worked
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with suggested policies or programs to limit these harmful practices, corporations
used their political clout to thwart these proposed remedies.
In this work, the corporate role in promoting disease was not our main focus,
but repeatedly we were stymied when we tried to make prevention the priority.
I wanted to understand how one small sector of society had accumulated the power
to block health progress. I wanted to devise useful strategies that my frustrated
students and colleagues could use to overcome this resistance they encountered.
The second path to this book was my work as a public health researcher and
teacher. My research has focused on understanding how social forces influence
health and inequalities in health. My teaching seeks to prepare public health professionals
and researchers to take action to reduce the forces that damage health.
Like many other researchers, I have come to appreciate the profound influence
of what have been called the social determinants of health: the day-to-day conditions
in which ordinary people live, the political processes that govern society,
and the stratifications of wealth and power that characterize today’s world.
But I have also been frustrated by the lack of impact of this new research on
social determinants of health. Too often, researchers describe the causes of ill health
without illuminating solutions. Too often the solutions they propose—ending the
stratification systems—seem pie-in-the-sky, however worthy this goal may be. For
me, analyzing the specific pathways by which the business and political decisions
that corporations make improve or harm health promises new insights on a key
social determinant of health. These insights can then guide policies to improve
health and find a better balance between private profit and public well-being.
The third path is my experiences as an activist. I came of age politically
in the antiwar and student movements of the 1960s. Over the years, I have
had the privilege of participating in or writing about these and other movements:
the environmental justice, labor, and women’s movements of the 1970s
and 1980s; the HIV and health care reform movements of the 1980s and 1990s;
and most recently, the food justice movement. In these encounters, I have been
fascinated to observe how communities mobilize to confront the threats they
perceive and how movements learn from each other—or fail to do so. Too often
the health campaigns against the tobacco, food, and alcohol corporations that
market unhealthy products or the “Big Pharma” efforts to promote diseases only
they can cure seem isolated, missing the opportunity to find new allies and win
bigger victories. In the book, I hope to discover common ground across the disparate
arenas where people are organizing to change harmful corporate practices.
The aftermath of the 2008 financial crisis further stimulated my activist juices.
The evidence suggests that banks and other financial institutions engaged in risky
practices that led our economy to the brink of meltdown. But when the public
demanded stronger oversight of the financial sector and prosecution of those
who had thrown so many people out of their homes, jobs, and communities,
“Big Business” blamed the problems on the government and on the foolish consumers
these lenders had targeted. If one sector of Big Business could evade any
responsibility for the most serious financial crisis since the Great Depression,
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surely the consumer sector would try the same strategy to avoid taking action to
reduce the slow-motion crisis of chronic diseases and injuries that their products
and practices are causing. This book is my effort to prevent such a future.
Some public health researchers are uncomfortable traveling on both the
research and advocacy roads. To me they are two paths to the same destination:
more just and healthy societies. My friend Dr. Jeremiah Stamler, a founder
of modern cardiovascular epidemiology and a veteran of many battles with the
food and pharmaceutical industries, once told me, “If a researcher isn’t willing
to follow his data into the policy arena, who will?” In looking to combine the
roles of researcher and activist, I am inspired by the founders of public health—
people such as Rudolf Virchow, Louis Villerme, Edwin Chadwick, and Alice
Hamilton—who demonstrated that it is possible to both study and act in the
political arena to change the conditions that make people sick.
When I speak in public about the impact of corporations on health, people
sometimes ask if I am against corporations. This seems like asking if one is
against families, religion, or government. People created these institutions over
the course of human history to solve particular problems. Of course corporations
have made important contributions to creating a better world, and of
course they are here to stay in one form or another for the foreseeable future.
But the question today is whether our political and economic arrangements
maximize the benefits that corporations bring to humanity and minimize the
harms. It does seem to me that many of society’s most serious problems—
income inequality, compromised democracy, environmental deterioration,
and accelerating climate change—are related to the current dominance of
corporations. My goal in Lethal but Legal is to explore how corporations contribute
to our society’s most important health problems and what we can do
to reduce this burden of premature death and preventable illness. If our efforts
to reduce corporate-induced health problems also contribute to reducing other
harms that corporations cause, so much the better.
Another question I am asked is why I have chosen to focus on only (!) six
industries. I have chosen to limit Lethal but Legal to the alcohol, automobile, fi rearms,
food and beverage, pharmaceutical, and tobacco industries for a few reasons.
These six are central to the global consumer economy, the largest portion
of the world’s economy today and in the future. They have a profound influence
on health behavior, lifestyle, and the physical environment. As a result, their
products and practices are associated with a significant proportion of the global
burden of disease, as I explain in Chapter 2. Finally, researchers have extensively
documented their impact on health, and health authorities and social movements
have taken action to reduce the threats these industries pose, providing
a body of evidence to inform action. Friends and colleagues often urge me to
add more industries to my portfolio of interest: energy, entertainment, tourism,
gaming, health care, and petrochemicals, to name a few. I encourage other
researchers to investigate these other important influences on health but believe
my already broad focus gives me more than enough to cover in this book.
For readers who want a roadmap, let me briefly summarize the journey this
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book covers. In Chapter 1, I describe the practices of three industries that have
since World War II had a profound impact on heath in the United States. The fast
food, soda, and snacks sectors of the food industry produce the products most
associated with the rise in obesity and diet-related health problems like diabetes.
As a result of some success in controlling its practices in the United States, the tobacco industry
has moved its lethal marketing campaigns to countries like Russia, Mexico, and Indonesia. The alcohol
industry has developed and marketed products to win over new populations: teens and young adults,
women, and blacks and Latinos. As a result, these groups are now seeing some
of the alcohol-related health problems previously concentrated among white
men. I use these three stories to illustrate the rise of what I call the corporate consumption
complex , a network of corporations, financial institutions, banks, trade
associations, advertising, lobbying and legal fi rms, and others that promote what
I call “hyperconsumption,” a pattern of consuming that is directly linked to premature
mortality and preventable illness or injury. Like the military-industrial
complex that jeopardized American values during the Cold War, today the corporate
consumption complex threatens public health, democracy, and sustainable
economic development.
Chapter 2 examines the state of global health today and charts the rise of
chronic condition diseases (called non-communicable diseases in most parts
of the world) and injuries here in the United States and in emerging nations
like Brazil, India, and China. I analyze the theories that have been proposed to
explain these increases, including population aging, the conquest of infectious
diseases, and changes in lifestyles related to health. I describe three more industries
that contribute to injuries and chronic conditions: the automobile, firearms,
and pharmaceutical industries, and summarize the growing evidence that
the business and political practices of these and the three industries described
in Chapter 1 have become the major modifiable causes of today’s top killers.
I also compare changing harmful corporate practices as a solution to two other
intervention strategies often proposed by policymakers and researchers: applying
biomedical advances to the prevention and treatment of chronic diseases and
modifying the unhealthy lifestyles of individuals who smoke, eat, or drink too
much or act in other ways that hurt their health.
How did this political and economic system that promotes consumption arise?
How is it different from earlier stages of free market economies? In Chapter 3,
I seek to answer these questions by telling the story of changes in corporate power
and practices since 1970. While the consumer economy started much earlier,
I make the case that domestic and global threats to the power of U.S. corporations
in that period were the precipitating cause of the transformation that has led to
today’s health problems. I also examine how the 2008 global economic crisis both
threatened and strengthened the corporate consumption complex.
In Chapter 4, I dissect the corporate consumption complex today, profiling
a few key players and describing its anatomy and the particular ways it
uses its power to achieve its goals. I examine two prototypical members of the
complex, the McDonald’s Corporation and the Pharmaceutical Research and
Manufacturers Association, showing the webs that bind the corporate consumption
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complex together. Today, even if its members do not always agree on everything,
the complex has become the dominant voice on public policy and public
health in the world.
The corporate consumption complex uses its political clout when it needs to,
but much of its impact is due to its success in promulgating and broadcasting an
ideology that supports its values and justifies its actions, even when they have
been shown to cause millions of preventable deaths. In Chapter 5, I describe key
elements of that ideology and the mechanisms that corporations and their allies
use to advance that ideology. Using public opinion polling data, I also examine
to what extent people here in the United States and elsewhere accept or challenge
the tenets of this ideology.
The corporate consumption complex hatched in the United States but is
now a global force. In Chapter 6, I describe how corporations have set the rules
for international trade and how they use organizations like the World Trade
Organization, the North American Free Trade Agreement, and other trade
groups to advance their business goals, often at the expense of public health. By
examining some key current conflicts—on global tobacco control, setting public
health standards for food advertising to children, and deciding when health
considerations can trump corporate patent protections, I illuminate the global
issues that divide public health advocates and corporate leaders.
In the last two chapters of Lethal but Legal, I ask how we can reverse the accelerating
epidemics of chronic conditions and injuries. What have we learned
from the myriad of efforts to change harmful corporate practices? What are the
elements of a political, policy, and scientific agenda that will enable the world to
realize its vast potential for reducing human suffering and inequalities in health?
Chapter 7 provides an overview and analysis of several strategies that have
been used to reduce corporate practices that harm health. I describe six efforts—
one from each of the six industries—to change harmful corporate practices,
describing the strategies the organizations and movements used, their accomplishments
and limitations, and the lessons they learned. While these disparate
strands of activity have different goals and operate in different settings, they
share a commitment to protecting public health by taking on special interests
that profit at the expense of health, and using flexible and creative strategies to
realize their health objectives. I analyze the barriers to a unified movement to
modify health-damaging corporate practices and suggest the pathways by which
we can weave these strands into a transformative force for improving health in
the United States and around the world.
Finally, in Chapter 8, I describe how we can restore the balance between corporations
and government; between profit and public health. I suggest actions
that can challenge the current dominance of the corporate consumption complex
and examine alternative paths to prosperity and well-being. I propose several
specific policy goals designed to bring together the diverse strands of the
emerging challengers to the corporate consumption complex and to speed the
process of changing harmful corporate practices.
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In the current political climate, these proposals may seem idealistic, even
naive. But in a society committed to public health and democracy, they would
be common sense. Public opinion polls show that the majority of Americans
support these propositions and would choose policies that achieve these
objectives. Recently, some researchers estimated that if current trends in obesity
and diabetes continued, our children and grandchildren can expect to
have shorter life spans than we do. 1 To escape the possibility of bequeathing
our children a world where the public health gains of recent centuries have
been reversed, we will need new ideas, new policies, new political will, and
new action. Converting these ideas into the practical steps that can restore
the balance between government and business constitutes the public health
priority of our time.
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